CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Chapter 8 : From the Molecular Pharmacology to the Medicinal Chemistry of Cannabinoids / editors, E. A. Rekka and P. N. Kourounakis

Contributor(s):

Material type: Article

Media type:

Carrier type:

ISBN:

Subject(s):

DDC classification:

Online resources:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Call number	Status	Date due	Barcode
Chapter in Books	Halal Development Corporation Library Open Shelves	EBCH 000876 (Browse shelf(Opens below))	Available

Previous								Next
Previous	EBCH 000873 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Stress Activates Corticotropin Releasing: Factor Signaling Pathways Implication in Functional Bowel Disorders / Chapter 5 :	EBCH 000874 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Design, Synthesis, and Pharmacological Evaluation of HighAffinity and Selectivity Sigma-1 and Sigma-2 Receptor Ligands / Chapter 6 :	EBCH 000875 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Synthesis of Biologically Active Taxoids / Chapter 7 :	EBCH 000876 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. From the Molecular Pharmacology to the Medicinal Chemistry of Cannabinoids / Chapter 8 :	EBCH 000877 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. An Appraisal of Fomocaines: Current Situation and Outlook / Chapter 9 :	EBCH 000878 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Ligands for the GABA Recognition Site at the GABAA Receptor: Structure-Activity Studies / Chapter 10 :	EBCH 000879 CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION. Strategies for Development of New Lead Structures for Inhibition of Acetylcholinesterase / Chapter 11 :	Next

There are no comments on this title.

to post a comment.

Back to results